HomeMarket News Livestock Vaccine Maker Zhengye Biotechnology Files...

Livestock Vaccine Maker Zhengye Biotechnology Files for $20M US IPO Livestock Vaccine Maker Zhengye Biotechnology Files for $20M US IPO

Actionable Trade Ideas

always free

Initial public offering concept, Elements of this image furnished by NASA

grapestock/iStock via Getty Images

Zhengye Biotechnology (ZYBT), a company dedicated to creating vaccines for livestock, has filed for a proposed $20M US IPO.

The company’s SEC filing did not specify any terms, but it signaled its intention to raise approximately $20M. US Tiger Securities is in the role of bookrunner, and the company aims to list its ordinary shares on Nasdaq under the symbol ZYBT.

Incorporated in the Cayman Islands, Zhengye primarily operates through a subsidiary in China. The company focuses on developing and marketing veterinary vaccines for swine, goats, sheep, cattle, poultry, and dogs. Its products are distributed in countries including China, Egypt, Vietnam, and Pakistan.

Exploring IPOs

Other recent IPO filings:

  • Latin American healthcare provider Auna files for $100M IPO
  • ArriVent, a lung cancer drug developer, files for $100M IPO
  • Gene editing biotech Metagenomi files for a proposed $100M IPO

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.